KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Gross Margin (2017 - 2025)

Historic Gross Margin for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to 45.74%.

  • Bionano Genomics' Gross Margin rose 1848200.0% to 45.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 45.97%, marking a year-over-year increase of 477600.0%. This contributed to the annual value of 1.23% for FY2024, which is 252500.0% down from last year.
  • Per Bionano Genomics' latest filing, its Gross Margin stood at 45.74% for Q3 2025, which was up 1848200.0% from 51.64% recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Gross Margin registered a high of 51.64% during Q2 2025, and its lowest value of 139.07% during Q3 2024.
  • Moreover, its 5-year median value for Gross Margin was 27.92% (2023), whereas its average is 21.1%.
  • Its Gross Margin has fluctuated over the past 5 years, first tumbled by -1685800bps in 2024, then soared by 1848200bps in 2025.
  • Over the past 5 years, Bionano Genomics' Gross Margin (Quarter) stood at 3.79% in 2021, then surged by 479bps to 21.97% in 2022, then rose by 3bps to 22.74% in 2023, then soared by 84bps to 41.86% in 2024, then grew by 9bps to 45.74% in 2025.
  • Its Gross Margin was 45.74% in Q3 2025, compared to 51.64% in Q2 2025 and 45.5% in Q1 2025.